Using Kaplan Meier survival curves, we compared whether high and low expression levels of DVL2 have any association with overall survival (OS) and distant metastases-free survival (DMFS) in HER2+ breast cancer patients. The gene discussed is ERBB2; the disease is breast carcinoma.